KRT19 and breast cancer: Based on our results, we conclude that even though the overall prevalence of CK19-negative breast carcinomas is very low, they do occur not only in tumors with a triple-negative or basal-like phenotype but also in breast cancers with a luminal phenotype, in which expression of luminal cytokeratins including CK19 is expected to be the rule.